A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)

RECRUITING

Liverpool Hospital /ID# 272002, Liverpool

RECRUITING

Calvary Mater Newcastle /ID# 272498, Waratah

RECRUITING

St Vincent's Hospital - Melbourne /ID# 271997, Fitzroy

RECRUITING

Epworth Hospital /ID# 272497, Richmond

RECRUITING

University of North Carolina at Chapel Hill /ID# 272454, Chapel Hill

RECRUITING

Hadassah Medical Center-Hebrew University /ID# 271253, Jerusalem

RECRUITING

Northwest Medical Specialties Tacoma /ID# 272506, Tacoma

RECRUITING

Rambam Health Care Campus /ID# 271256, Haifa

RECRUITING

Rabin Medical Center /ID# 272073, Petah Tikva

RECRUITING

The Chaim Sheba Medical Center /ID# 271251, Ramat Gan

RECRUITING

Tel Aviv Sourasky Medical Center /ID# 271252, Tel Aviv

RECRUITING

Nagoya City University Hospital /ID# 271427, Nagoya

RECRUITING

University Hospital Kyoto Prefectural University of Medicine /ID# 271911, Kyoto

RECRUITING

The University of Osaka Hospital /ID# 271636, Suita-shi

RECRUITING

Japanese Red Cross Medical Center /ID# 272018, Shibuya-ku

RECRUITING

The Jikei University School of Medicine /ID# 272091, Tokyo